SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-028359
Filing Date
2020-10-15
Accepted
2020-10-15 19:18:28
Documents
1
Period of Report
2020-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7466
  Complete submission text file 0000899243-20-028359.txt   9133
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Issuer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVENUE NESTLE 55 VEVEY V8 CH-1800
Business Address AVENUE NESTLE 55 VEVEY V8 CH-1800 41-21-924-1111
Societe des Produits Nestle S.A. (Reporting) CIK: 0001803539 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37519 | Film No.: 201242416